Are Options Traders Bullish on ADMS?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon
Adamas Pharmaceuticals Inc.

ADMS

27.13

-0.11

-0.4%

After Hours:

27.13

0.00

0.0%

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

Stock Price
Open: 27.22
Prev. Close: 27.24
Low/Hi: 26.90 - 27.50
52-Week: 13.50 - 44.00
Volumes
Equity: 214,517
90-Day Avg: 667,135
Option: 28
90-Day Avg: 387
Volatility
Todays Stock Vol: 20.6
20-Day (HV): 44.9
52-Week (HV): 64.8
30-Day IV: 43.3 -5.4
IV Pct Rank: 1% Subdued
Fundamental
Div. Yield:
Earnings: 7-Aug (Est.)
P/E Ratio:
Market Cap: 735.0 M
Short Int Pct: 0.0%
Pct Held By Inst.: 87.7%
Stock Info
Type: Common
Sector: Healthcare
Industry: Drugs - Generic

About ADMS

Adamas Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on those affected by chronic disorders of the central nervous system. The company achieves this by modifying the pharmacokinetic profiles of approved drugs to create novel therapeutics for use alone or in fixed-dose combination products. Adamas is currently developing its lead wholly-owned product candidate, ADS-5102, for a complication associated with the treatment of Parkinson's disease known as levodopa-induced dyskinesia, or LID, and is evaluating other potential indications. The company's portfolio also includes two approved products with Forest Laboratories Holdings Limited (a subsidiary of Actavis plc), Namzaric(TM) and Namenda XR(R). Forest is responsible for marketing both products in the United States under an exclusive license from Adamas. For more information, please visit www.adamaspharma.com.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ADMS is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 367.1 M 3.67133E+08 203 203 0.03% 0.000323938 262 K 261858
EQWS Invesco Russell 2000 Equal Weight ETF 25.8 M 2.58E+07 1,987 1987 0.03% 0.0003 8 K 7654
FHLC Fidelity MSCI Health Care Index ETF 1.2 B 1.2E+09 354 354 0.01% 0.00014847 184 K 183516
IBB iShares Nasdaq Biotechnology Index Fund 9.6 B 9.55625E+09 192 192 0.09% 0.0009 8.5 M 8529930
ITOT iShares Core S&P Total U.S. Stock Market ETF 14.8 B 1.48461E+10 3,453 3453 0.0% 0 487 K 487405
IWC iShares Microcap ETF 1.1 B 1.07967E+09 1,439 1439 0.14% 0.0014 1.5 M 1528670
IWM iShares Russell 2000 ETF 46.9 B 4.69434E+10 2,019 2019 0.03% 0.0003 12.5 M 1.24728E+07
IWN iShares Russell 2000 Value ETF 10.6 B 1.05611E+10 1,363 1363 0.03% 0.0003 2.8 M 2809880
IWO iShares Russell 2000 Growth ETF 11.2 B 1.12072E+10 1,220 1220 0.03% 0.0003 3.0 M 3044170
IWV iShares Russell 3000 ETF 9.6 B 9.5622E+09 3,005 3005 0.0% 0 189 K 188852
SBIO ALPS Medical Breakthroughs ETF 228.6 M 2.28578E+08 115 115 0.47% 0.0047 1.1 M 1074316
UBIO Proshares UltraPro Nasdaq Biotechnology 35.0 M 3.50165E+07 197 197 0.02% 0.00015228 18 K 18224
URTY ProShares UltraPro Russell2000 179.0 M 1.7901E+08 2,029 2029 0.01% 5.05628E-05 30 K 30400
UWM ProShares Ultra Russell2000 257.2 M 2.57176E+08 2,029 2029 0.01% 9.01833E-05 52 K 51919
XBI SPDR Series Trust SPDR S&P Biotech ETF 5.6 B 5.59843E+09 122 122 0.9% 0.00898287 49.7 M 4.965116E+07
FAD First Trust Multi Cap Growth AlphaDEX Fund 190.0 M 1.9002E+08 675 675 0.05% 0.0005 95 K 95010
FYC First Trust Small Cap Growth AlphaDEX Fund 353.2 M 3.53181E+08 262 262 0.26% 0.0026 918 K 918271
FYX First Trust Small Cap Core AlphaDEX Fund 727.7 M 7.27706E+08 526 526 0.13% 0.0013 946 K 946018

Wait, Before You Leave...